Peer navigators and mobile clinics aim to slash HIV rates in rural south african youth
NCT ID NCT05405582
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This trial tests a community-based approach to HIV prevention for young people aged 15-30 in rural KwaZulu-Natal, South Africa. Peer navigators guide participants to mobile clinics that offer sexual health services, including HIV testing, PrEP, and contraception. The goal is to reduce the number of youth with transmissible HIV by making prevention more accessible and tailored to individual risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Community-based HIV prevention including PrEP and sexual health services
- What this could lead to
- If successful, this approach could reduce new HIV infections among young people in rural areas and serve as a model for other communities.
- What could go wrong
- This is a large trial, but results depend on participation and real-world implementation. The intervention may not work as well outside this specific region.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV -1 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Africa Health Research Institute
Somkele, KwaZulu-Natal, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo
- Long-acting HIV shot studied in patients with severe kidney problems
- RNA vaccine aims to control HIV without daily pills
- Herbal formula may help HIV patients whose immune systems Don't fully recover